CSIMarket


Prestige Consumer Healthcare Inc   (PBH)
Other Ticker:  
 

Prestige Consumer Healthcare Inc

PBH's Fundamental analysis








Looking into Prestige Consumer Healthcare Inc growth rates, revenue grew by 2.33 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 283

Major Pharmaceutical Preparations industry recorded deterioration of revenues by

Prestige Consumer Healthcare Inc 's net income grew by 2.13 % in III. Quarter 2023 year on year, above company average,

More on PBH's Growth


Prestige Consumer Healthcare Inc
realized net loss in trailing twelve months.

Prestige Consumer Healthcare Inc realized cash outflow of $ -0.45per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
341.15
PE TTM    
Company's Price to Sales ratio is at 3.01.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.36.


More on PBH's Valuation
 
 Total Debt (Millions $) 1,199
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 2,157,143
 Net Income/Employee (TTM) $ -147,762
 Receivable Turnover (TTM) 6.89
 Tangible Book Value (Per Share $) -25.05

Prestige Consumer Healthcare Inc
realized net loss in trailing twelve months.

Prestige Consumer Healthcare Inc realized cash outflow of $ -0.45per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
341.15
PE TTM    
Company's Price to Sales ratio is at 3.01.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.36.

Prestige Consumer Healthcare Inc Price to Book Ratio is at 2.13 lower than Indusry Avg. of 1527.54. and higher than S&P 500 Avg. of 0.01

More on PBH's Valuation

  Market Capitalization (Millions $) 3,410
  Shares Outstanding (Millions) 50
  Employees 525
  Revenues (TTM) (Millions $) 1,133
  Net Income (TTM) (Millions $) -78
  Cash Flow (TTM) (Millions $) -23
  Capital Exp. (TTM) (Millions $) -9
  Total Debt (Millions $) 1,199
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 2,157,143
  Net Income/Employee(TTM) $ -147,762
  Receivable Turnover Ratio (TTM) 6.89
  Tangible Book Value (Per Share $) -25.05

  Market Capitalization (Millions $) 3,410
  Shares Outstanding (Millions) 50
  Employees 525
  Revenues (TTM) (Millions $) 1,133
  Net Income (TTM) (Millions $) -78
  Cash Flow (TTM) (Millions $) -23
  Capital Exp. (TTM) (Millions $) -9


    PBH's Profitability Comparisons
Prestige Consumer Healthcare Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2023 to 30.8 % from 30.85 % in II. Quarter.

Prestige Consumer Healthcare Inc net profit margin of 43.49 % is currently ranking no. 14 in Major Pharmaceutical Preparations industry, ranking no. 26 in Healthcare sector and number 214 in S&P 500.





  Ratio
   Capital Ratio (MRQ) 3.09
  Total Debt to Equity (MRQ) 0.75
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.34
  Inventory Turnover Ratio (TTM) 3.15



Prestige Consumer Healthcare Inc faced margin deterioraten, primarily through cost pressure. Operating Margin fell in III. Quarter 2023 to 30.8 % from 30.85 % in II. Quarter.

Prestige Consumer Healthcare Inc net profit margin of 43.49 % is currently ranking no. 14 in Major Pharmaceutical Preparations industry, ranking no. 26 in Healthcare sector and number 214 in S&P 500.

More on PBH's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com